Kawasaki disease: guidelines of Italian Society of Pediatrics, part II - treatment of resistant forms and cardiovascular complications, follow-up, lifestyle and prevention of cardiovascular risks | Italian Journal of Pediatrics | Full Text
Frontiers | Thirty Years of Kawasaki Disease: A Single-Center Study at the University Hospital of Lausanne
Mortality among Children with Kawasaki Disease in Japan | NEJM
Recurrent Kawasaki disease presenting as acute airway obstruction
Frontiers | The Epidemiology and Pathogenesis of Kawasaki Disease
Kawasaki disease: insights into pathogenesis and approaches to treatment | Nature Reviews Rheumatology
Cumulative recurrence rates of Kawasaki disease calculated by different... | Download Scientific Diagram
Clarithromycin Plus Intravenous Immunoglobulin Therapy Can Reduce the Relapse Rate of Kawasaki Disease: A Phase 2, Open‐Label, Randomized Control Study | Journal of the American Heart Association
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association | Circulation
Frontiers | Epidemiology of Kawasaki Disease in Europe
Kawasaki disease recurrence in the COVID-19 era: a systematic review of the literature | Italian Journal of Pediatrics | Full Text
Mortality among Children with Kawasaki Disease in Japan | NEJM
Medicina | Free Full-Text | Clinical Manifestations of Kawasaki Disease at Different Age Spectrum: A Ten-Year Study
Children | Free Full-Text | Major Complication Following Kawasaki Disease in an Infant—The Development of Apical Infarction and Aneurysm Formation
Abstract 134: Early Immunoglogulin Therapy and Outcomes of Kawasaki Disease | Circulation
Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a
Environmental epidemiology of Kawasaki disease: Linking disease etiology, pathogenesis and global distribution | PLOS ONE
Combination therapy reduces risk for abnormalities, treatment failure in Kawasaki disease
Rheumato | Free Full-Text | Kawasaki Disease: Management Challenges during COVID-19 Pandemic with an Upsurge in Multisystem Inflammatory Syndrome in Children
Refractory Kawasaki disease - UpToDate
Clinical characteristics of patients with recurrent Kawasaki disease: a nationwide cohort study of 19 456 patients with minimum 3-year follow up | Archives of Disease in Childhood
Frontiers | Increased Incidence of Kawasaki Disease in Taiwan in Recent Years: A 15 Years Nationwide Population-Based Cohort Study
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease | Circulation
Is it Kawasaki Disease or Multisystem Inflammatory Syndrome in Children? - ScienceDirect
